NCT00460057View on ClinicalTrials.gov

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

February 28, 2007

Conditions
Osteoporosis
Interventions
DRUG

Alendronate

Take two tablets (alendronate 10 mg) once weekly with a full glass of plain water in the morning after an overnight fast and to refrain from lying down or taking any other beverage or food for at least 1 h thereafter

All Listed Sponsors
lead

Eulji University Hospital

OTHER

NCT00460057 - The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss | Biotech Hunter | Biotech Hunter